Epilepsy Linked To Higher Risk Of Young-onset Dementia
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

A study published in Neurology found that epilepsy was associated with a higher likelihood of young-onset dementia, diagnosed before age 65. In a French follow-up analysis, the adjusted likelihood was six times higher for people newly diagnosed with epilepsy than for those without epilepsy, while researchers stressed that the study cannot show epilepsy causes dementia and that absolute risk was low.

A study published October 14 in Neurology found that people with epilepsy were more likely to be diagnosed with young-onset dementia—dementia that develops before age 65—than people without epilepsy. The researchers said the results show an association, not proof that epilepsy directly causes dementia, and noted that the absolute risk remained low.

The research combined two approaches using health data from France and Sweden. In the first, researchers compared people diagnosed with young-onset dementia with people of the same age and sex who did not have dementia, then checked records for epilepsy diagnoses or epilepsy medication use in the preceding 10 years. The French comparison included 11,360 people with dementia and 113,600 without it; the Swedish comparison included 16,433 and 164,330, respectively.

In France, an epilepsy diagnosis appeared in 12.5% of people with young-onset dementia, compared with 1.2% of those without dementia. Epilepsy medication use was recorded for 27.3% of the dementia group and 10.3% of the comparison group. The report said the pattern was similar in Sweden, but did not provide the corresponding Swedish percentages in the supplied results.

The second analysis followed people in France over time. Among people aged 30 to 55 newly diagnosed with epilepsy in 2008, 2.2% developed young-onset dementia during up to 10 years of follow-up. The figure was 1.7% among people with existing epilepsy and 0.2% among people without epilepsy. After researchers adjusted for factors including stroke, mood disorders and traumatic brain injury, newly diagnosed epilepsy was associated with six times the likelihood of young-onset dementia compared with no epilepsy; existing epilepsy was associated with a 74% higher likelihood.

At a glance
reportWhen: Published October 14, 2026
The developmentA study published October 14, 2026, reported an association between epilepsy and young-onset dementia using health records from France and Sweden.

Implications for Epilepsy Care

The findings may matter for how clinicians and patients discuss cognitive health alongside epilepsy care. The study authors said the results support considering dementia prevention and assessment of cognitive risks for people with epilepsy, including attention to potentially modifiable factors such as high blood pressure and other cardiovascular risks.

That implication should not be read as a recommendation to treat epilepsy as an inevitable path to dementia. In the French follow-up, most participants with epilepsy did not develop young-onset dementia during the study period: the reported proportion was 2.2% among those newly diagnosed and 1.7% among those with existing epilepsy. The comparison groups and adjustment methods help describe an association across populations, but cannot establish why it occurs or predict an individual person’s outcome.

The study also adds evidence on dementia diagnosed before age 65, an area the researchers described as having had limited prior evidence about its relationship with epilepsy. If the association is borne out in further research, it could help guide conversations about cognitive monitoring and risk-factor management. For now, the results are a reason to study the relationship further, not evidence that epilepsy itself causes dementia.

Amazon

epilepsy medication organizer

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Two Designs, Two Countries

Earlier research had linked epilepsy with late-onset dementia, according to study author Vincent Navarro, but evidence concerning dementia before age 65 was more limited. The new work, titled “Association between epilepsy and young-onset dementia,” used two complementary methods: a retrospective comparison of dementia cases and matched controls in France and Sweden, and a follow-up of people with and without epilepsy in France.

The retrospective analyses looked for epilepsy diagnoses or medication use in records up to 10 years before the dementia diagnosis. The follow-up analysis tracked dementia diagnoses for up to 10 years among people aged 30 to 55. These are observational methods: they can identify patterns in existing records but do not assign epilepsy or establish a biological mechanism linking the conditions.

The study was supported by the French National Research Agency and published in Neurology, the medical journal of the American Academy of Neurology. Its authors included Navarro of Sorbonne University in Paris. The report’s findings are based on national databases in two high-income countries with universal health care coverage.

Amazon

memory aid for epilepsy patients

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Limits of the Available Evidence

The study shows a statistical association, but does not establish that epilepsy causes dementia. Adjusting for stroke, mood disorders and traumatic brain injury accounts for some factors that could affect the results, but cannot rule out all alternative explanations or determine the direction of the relationship.

The researchers lacked detailed information about the type or cause of dementia and the type of epilepsy in the cases. That limits what can be concluded about whether particular forms of either condition account for the pattern. The record-based design also means the findings reflect diagnoses and medication records rather than a detailed account of each participant’s condition.

Because the data came from France and Sweden, both high-income countries with universal health coverage, the authors cautioned that results may not apply to other health systems or populations. The supplied report does not give the Swedish percentages for epilepsy diagnoses or medication use in the matched comparison. It also does not establish whether the association varies by epilepsy type, dementia subtype, or other characteristics.

Amazon

cognitive health supplements for epilepsy

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Further Study and Clinical Follow-Up

The publication reports the study’s findings; the supplied material does not announce a further trial, a new guideline, or a scheduled next research milestone. Further research would be needed to test whether the association appears in other populations and to clarify how epilepsy type, dementia subtype and other health factors relate to the results.

For clinical care, Navarro’s comments point to earlier assessment of cognitive risks and management of modifiable factors as areas to consider, rather than a proven dementia-prevention intervention from this study. The research does not specify a screening schedule or show that a particular intervention prevents young-onset dementia. Any individual decisions about cognitive concerns or risk factors should be discussed with a qualified health professional.

Amazon

dementia prevention tools

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

What is young-onset dementia?

Young-onset dementia, also called early-onset dementia, is dementia that develops before age 65.

Does this study prove epilepsy causes dementia?

No. The researchers found an association in health records, but the observational study cannot prove that epilepsy directly causes young-onset dementia.

How many people with epilepsy developed young-onset dementia in the follow-up?

Over up to 10 years, 2.2% of people newly diagnosed with epilepsy developed young-onset dementia, compared with 1.7% of those with existing epilepsy and 0.2% of those without epilepsy in the French analysis.

What did the adjusted risk comparison show?

After adjustment for factors including stroke, mood disorders and traumatic brain injury, people newly diagnosed with epilepsy were six times more likely to develop young-onset dementia than people without epilepsy. People with existing epilepsy were 74% more likely. These relative comparisons do not mean that dementia was common: the reported absolute percentages were low.

Can the findings be applied to everyone with epilepsy?

Not with certainty. The study used records from France and Sweden, and the authors said the findings may not apply in other settings. It also lacked detailed information about the types of epilepsy and dementia involved.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
FALL

Fall Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Lifestance Health Group Surges In Global Coverage

Lifestance Health Group has increased its global coverage, with mentions rising 24-fold, signaling a major expansion in its healthcare network.

Why We Keep Accepting The Same Painful Relationship Patterns

Exploring why individuals often accept recurring harmful relationship patterns, the psychological roots, and what this means for personal growth.

Friends Of BrainHealth Grants Advance Dementia Prevention And Brain Health Research

Friends of BrainHealth awarded seven 2026 research grants covering early detection, dementia risk, caregiver well-being and cognitive resilience.

Health Sciences Surges In Global Coverage

Health sciences are experiencing a notable surge in international media mentions, highlighting increased global interest and focus on health research and innovations.